Published in Stroke on January 01, 1991
Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center | NCT00005326
Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer (2010) 1.75
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood (2011) 1.37
Prospects for primary stroke prevention in children with sickle cell anaemia. Br J Haematol (2012) 0.89
Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood (2011) 0.85
Stroke in Children with Sickle Cell Disease. Curr Treat Options Neurol (2004) 0.79
Hypoxemia, oxygen content, and the regulation of cerebral blood flow. Am J Physiol Regul Integr Comp Physiol (2015) 0.78
Changes of the carotid artery Doppler flow velocity pattern after sublingual nitroglycerin in patients with hypertension. Korean J Intern Med (1998) 0.75
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol (1984) 5.21
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69
Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther (1994) 4.18
Mitochondrial myopathies. Ann Neurol (1985) 3.81
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology (2006) 3.46
Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med (1992) 3.38
The Harvard Cooperative Stroke Registry: a prospective registry. Neurology (1978) 3.19
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol (1994) 2.82
Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. N Engl J Med (1997) 2.82
Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol (1992) 2.59
A micromethod for free erythrocyte porphyrins: the FEP test. J Lab Clin Med (1973) 2.44
Broca aphasia: pathologic and clinical. Neurology (1978) 2.43
The New York Islands AVM Study: design, study progress, and initial results. Stroke (2003) 2.42
Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40
Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis. Bull World Health Organ (1966) 2.30
Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology (1997) 2.28
Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology (1995) 2.24
Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology (1994) 2.21
Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol (1987) 2.20
Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20
Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord (1992) 2.15
Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry (2001) 2.14
The natural history of CADASIL: a pooled analysis of previously published cases. Stroke (1999) 2.14
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke (2001) 1.97
Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92
Behavioral studies of aphasia: methods of investigation and analysis. Neuropsychologia (1971) 1.92
Separation of erythrocytes according to age on a simplified density gradient. J Lab Clin Med (1974) 1.89
Failure to detect linkage between Xg and other X-borne loci in Sardinians. Ann Hum Genet (1966) 1.82
Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol (1983) 1.82
Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology (2003) 1.81
Hypothalamic-midbrain dysregulation syndrome: hypertension, hyperthermia, hyperventilation, and decerebration. J Child Neurol (1991) 1.80
Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke (2000) 1.79
Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology (1992) 1.78
Cerebrovascular reactivity and vasospasm after subarachnoid hemorrhage: a pilot study. Neurology (2006) 1.78
Chronic ketosis and cerebral metabolism. Ann Neurol (1978) 1.76
The epidemiology of brain arteriovenous malformations. Neurosurgery (2000) 1.75
Unruptured brain arteriovenous malformations should be treated conservatively: yes. Stroke (2007) 1.75
Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke (1998) 1.75
Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol (1994) 1.74
Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet (1997) 1.73
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency. J Clin Invest (1968) 1.72
Distinct syndromes of hemineglect. Arch Neurol (1992) 1.71
'Steal' is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke (1995) 1.70
Threshold for lead damage to heme synthesis in urban children. Proc Natl Acad Sci U S A (1982) 1.68
The pilot Stroke Data Bank: definition, design, and data. Stroke (1984) 1.67
Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med (2007) 1.66
Stroke in south Alabama: incidence and diagnostic features--a population based study. Stroke (1984) 1.66
Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases. Arch Neurol (1974) 1.65
Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology (1992) 1.61
Clinical determinants of dementia related to stroke. Ann Neurol (1993) 1.58
Infarcts with a cardiac source of embolism in the NINCDS Stroke Data Bank: historical features. Neurology (1990) 1.58
Perfusion insufficiency in limb-shaking transient ischemic attacks. Stroke (1990) 1.58
Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke (2003) 1.55
Transient monocular blindness associated with cocaine abuse. Neurology (1993) 1.53
The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol (1993) 1.53
The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics (1993) 1.51
Seizure threshold in electroconvulsive therapy. Effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry (1987) 1.51
Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme. J Clin Invest (1979) 1.50
The topography of callosal reading pathways. A case-control analysis. Brain (1992) 1.50
Identification of the cDNA for human red blood cell-specific hexokinase isozyme. Blood (1997) 1.50
Clinical discriminators of lobar and deep hemorrhages: the Stroke Data Bank. Neurology (1991) 1.50
Wallenberg's lateral medullary syndrome. Clinical-magnetic resonance imaging correlations. Arch Neurol (1993) 1.50
The role of transcranial Doppler in confirming brain death: sensitivity, specificity, and suggestions for performance and interpretation. Neurology (1990) 1.49
Life-threatening organophosphate-induced delayed polyneuropathy in a child after accidental chlorpyrifos ingestion. J Pediatr (1993) 1.49
Pressure autoregulation is intact after arteriovenous malformation resection. Neurosurgery (1993) 1.49
CADASIL in a North American family: clinical, pathologic, and radiologic findings. Neurology (1998) 1.47
Clinical and angiographic features of carotid transient ischemic attacks. N Engl J Med (1977) 1.46
The nature of posttraumatic epilepsy. J Neurosurg (1979) 1.46
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.45
An isozyme of hexokinase specific for the human red blood cell (HKR) Blood (1990) 1.45
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. J Nucl Med (1993) 1.45
Laryngopharyngeal sensory testing with modified barium swallow as predictors of aspiration pneumonia after stroke. Laryngoscope (1997) 1.45
Regional cerebral blood flow in mood disorders, V.: Effects of antidepressant medication in late-life depression. Am J Geriatr Psychiatry (2000) 1.44
Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology (2001) 1.43
Relationship of transcranial Doppler flow velocities and arteriovenous malformation feeding artery pressures. Stroke (1993) 1.43
Cerebellar atrophy with basilar artery occlusion. Eur J Med Res (1997) 1.43
Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study. Neurology (2004) 1.42
Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology (1993) 1.42
Stable isotope dilution analysis of 4-hydroxybutyric acid: an accurate method for quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduria. Biomed Environ Mass Spectrom (1990) 1.41
Left hemiparalexia. Neurology (1992) 1.41
Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology (1989) 1.40
Determinants of early recurrence of cerebral infarction. The Stroke Data Bank. Stroke (1989) 1.40
Elevated AMP pyrophosphorylase activity in congenital IMP pyrophosphorylase deficiencey (Lesch-Nyhan disease). J Lab Clin Med (1969) 1.40
Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke (1993) 1.39